Antithrombotic effects of low-molecular-weight heparin calcium (LMWH-Ca) in experimental models - a critical analysis of clinical trials

Author： Ji H.   Li S.P.   Cheng X.   Cheng H.R.   Ng T.B.   Li P.   Li N.S.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.33, Iss.2, 1999-08, pp. : 207-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pellets for oral administration of low-molecular-weight heparin

By Scala-Bertola Julien   Gajdziok Jan   Rabišková Miloslava   Bonneaux François   Lecompte Thomas   Sapin Anne   Maincent Philippe  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1503-1510

Informa Healthcare

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin in Acute Coronary Syndromes

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Low molecular weight heparin (LMWH) is acceptable to patients with advanced cancer receiving palliative care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis

By  

Current Drug Delivery, Vol. 13, Iss. 5, 2016-08 ,pp. : 698-710

Bentham Science Publishers

Access to resources Recommend Favorite

The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity

By Deepa P.R.   Varalakshmi P.  

European Journal of Pharmacology, Vol. 478, Iss. 2, 2003-10 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite